Effect of Ivermectin mass drug administration on the COVID-19 Pandemic: Ecological study with special reference to the State of Uttarakhand, India

Nidhi Uniyal; Hem Chandra Pandey; Ashutosh Sayana; Narayan Jeet; Anurag Agrawal; Sadhana Awasthi; Saurabh Agarwal; Puneet Kumar Gupta

doi:10.53730/ijhs.v6nS1.4792

Effect of Ivermectin mass drug administration on the COVID-19 Pandemic

Ecological study with special reference to the State of Uttarakhand, India

https://doi.org/10.53730/ijhs.v6nS1.4792

Authors

Nidhi Uniyal Associate Professor, Department of Medicine, Government Doon Medical College, Dehradun, HNB Medical Education University, Uttarakhand
Hem Chandra Pandey Vice Chancellor, HNB Medical Education University, Uttarakhand
Ashutosh Sayana Principal, Government Doon Medical College, Dehradun, HNB Medical Education University, Uttarakhand
Narayan Jeet Professor, Department of Medicine, Government Doon Medical College, Dehradun, HNB Medical Education University Uttarakhand
Anurag Agrawal Professor, Department of TB and Chest Medicine, Government Doon Medical College, Dehradun, HNB Medical Education University, Uttarakhand
Sadhana Awasthi Professor, Department of Community Medicine, Shushila Tiwari Medical College, Haldwani, HNB Medical Education University, Uttarakhand
Saurabh Agarwal
sagarwal685@gmail.com
Professor, Department of Medicine, SGRRIMHS, Dehradun, Uttarakhand
Puneet Kumar Gupta Assistant Professor, ICFAI Business School, The ICFAI University, Dehradun, Uttarakhand

Keywords:

COVID-19, Ivermectin, mass drug administration

Abstract

Uttarakhand, a hilly state of India adopted the strategy of mass drug administration of ivermectin during the second wave of COVID-19 pandemic as a measure to control the peak due to failing health infrastructure and health facility with sudden cases surge. This study was hereby planned with an aim of analyzing the effect of mass drug administration of ivermectin on the COVID-19 pandemic progression in the State of Uttarakhand. The trend of pandemic progression in five states of India was studied taking case growth rate, active case rate and case fatality rate as indicators. The percentage change in the indicators with the progression of pandemic was calculated for all five states and compared. The projected increased number of deaths, the state of Uttarakhand would have experienced, if the state had the declining average case growth of the other states taken for study was also calculated. The data analysis shows that the Uttarakhand had a sharp fall in the active cases by 3 to 4 weeks post lockdown, the period corresponding with maximum coverage of ivermectin distribution in the state.

Downloads

Download data is not yet available.

References

Arevalo, A. P., Pagotto, R., Pórfido, J. L., Daghero, H., Segovia, M., Yamasaki, K., ... & Crispo, M. (2021). Ivermectin reduces in vivo coronavirus infection in a mouse experimental model. Scientific Reports, 11(1), 1-12.

Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral research, 178, 104787. https://doi.org/10.1016/j.antiviral.2020.104787

Chaccour, C., Casellas, A., Blanco-Di Matteo, A., Pineda, I., Fernandez-Montero, A., Ruiz-Castillo, P., ... & Fernández-Alonso, M. (2021). The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine, 32, 100720. https://doi.org/10.1016/j.eclinm.2020.100720

Hellwig, M. D., & Maia, A. (2021). A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin. International journal of antimicrobial agents, 57(1), 106248. https://doi.org/10.1016/j.ijantimicag.2020.106248

Meo, S. A., Abukhalaf, A. A., Alomar, A. A., AlMutairi, F. J., Usmani, A. M., & Klonoff, D. C. (2020). Impact of lockdown on COVID-19 prevalence and mortality during 2020 pandemic: observational analysis of 27 countries. European journal of medical research, 25(1), 1-7.

Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., ... & Ferguson, N. M. (2020). Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet infectious diseases, 20(6), 669-677.

Zaidi, A. K., & Dehgani-Mobaraki, P. (2021). The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review. The Journal of antibiotics, 1-12.

Published

15-03-2022

How to Cite

Uniyal, N., Pandey, H. C., Sayana, A., Jeet, N., Agrawal, A., Awasthi, S., Agarwal, S., & Gupta, P. K. (2022). Effect of Ivermectin mass drug administration on the COVID-19 Pandemic: Ecological study with special reference to the State of Uttarakhand, India. International Journal of Health Sciences, 6(S1), 450–462. https://doi.org/10.53730/ijhs.v6nS1.4792

Download Citation

Issue

Vol. 6 No. S1 (2022)

Section

Peer Review Articles

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.

Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.